Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Shareholder Class Actions During, and After, COVID-19

BY Margaret A. Dale
July 01, 2020

As the global economy surges up and down, companies continue to work to represent accurately to their investors the current state of affairs. Given the turmoil in the markets, an increasing number of plaintiffs are bringing shareholder class action suits, citing corporate statements about COVID-19. Often, these lawsuits point to statements from the company's most recent SEC filings or associated press releases, and argue that the company knew that those statements were false or materially misleading based on actions that the company took not long after its reporting date. As first-quarter earnings season draws to a close, now is a good time to reflect on the shareholder class actions that have been brought to date related to COVID-19, and others potentially yet to come.

This article begins by discussing the most recent putative class action lawsuits related to COVID-19, and concludes by evaluating implications for future lawsuits.

Colony Capital, Inc.

On May 26, the plaintiffs filed a securities-fraud class action lawsuit against Colony Capital, Inc., a global investment firm with a focus on digital real estate, and several of its officers, in the Central District of California. The lawsuit alleges, in part, that Colony made statements in its recent public filings (4Q2019 10-Q, 2019 10-K), and associated earnings calls and press releases that painted a rosy picture of the company's health care and hospitality segments and their respective liquidity positions. For example, the complaint cites the 4Q2019 press release and the 2019 10-K, which both purportedly stated that "with respect to the health care and hospitality units, the Company successfully addressed all material near-term debt maturities allowing the respective business unit leaders to focus on improving cash flows through operational management and capital expenditures."

The complaint continues that the "truth" came to light in the following months, when the company disclosed that its health care and hospitality portfolio companies had defaulted on more than $3 billion in debt as a "result of the economic fallout from COVID-19." The complaint alleges that the company's public statements regarding its health care and hospitality segment were overly optimistic and materially misleading as they failed to disclose that the portfolio companies in those segments "carried unsustainable levels of debt secured by hotels and health care-related properties and were thus at a significant risk of default" due to the prospective impact of COVID-19. The company disclosed the default in its May 8 press release, after which Colony's stock price fell $0.08 per share, or 3.81%, to close at $2.02 per share on May 8.

Sorrento Therapeutics, Inc.

On May 26, the plaintiffs filed a securities-fraud class action lawsuit against Sorrento Therapeutics, Inc. and several of its officers in the Southern District of California. Sorrento had been developing COVID-19 antibody products that could potentially be used to "block and neutralize" the virus in at-risk populations and recently infected individuals. The complaint focuses on May 15, when the company issued a press release allegedly stating that the antibody "demonstrated 100% inhibition" of virus infections, and when the CEO gave an interview where he characterized the breakthrough as a "cure." After these statements the company's share price increased more than 280%.

This premium content is locked for Entertainment Law & Finance subscribers only

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts

For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473

Read These Next
Yachts, Jets, Horses & Hooch: Specialized Commercial Leasing Models Image

Defining commercial real estate asset class is essentially a property explaining how it identifies — not necessarily what its original intention was or what others think it ought to be. This article discusses, from a general issue-spot and contextual analysis perspective, how lawyers ought to think about specialized leasing formats and the regulatory backdrops that may inform what the documentation needs to contain for compliance purposes.

Hyperlinked Documents: The Latest e-Discovery Challenge Image

As courts and discovery experts debate whether hyperlinked content should be treated the same as traditional attachments, legal practitioners are grappling with the technical and legal complexities of collecting, analyzing and reviewing these documents in real-world cases.

Identifying Your Practice's Differentiator Image

How to Convey Your Merits In a Way That Earns Trust, Clients and Distinctions Just as no two individuals have the exact same face, no two lawyers practice in their respective fields or serve clients in the exact same way. Think of this as a "Unique Value Proposition." Internal consideration about what you uniquely bring to your clients, colleagues, firm and industry can provide untold benefits for your law practice.

Risks and Ad Fraud Protection In Digital Advertising Image

The ever-evolving digital marketing landscape, coupled with the industry-wide adoption of programmatic advertising, poses a significant threat to the effectiveness and integrity of digital advertising campaigns. This article explores various risks to digital advertising from pixel stuffing and ad stacking to domain spoofing and bots. It will also explore what should be done to ensure ad fraud protection and improve effectiveness.

Turning Business Development Plans Into Reality Image

This article offers practical insights and best practices to navigate the path from roadmap to rainmaking, ensuring your business development efforts are not just sporadic bursts of activity, but an integrated part of your daily success.